Group 1 - Zhongwei Company plans to acquire controlling stake in Hangzhou Zhonggui through share issuance, with stock suspension starting December 19, 2025, for up to 10 trading days [1] - Qibin Group's subsidiary plans to establish Shenzhen Qibin New Energy Technology Co., with a registered capital of 600 million yuan to enhance photovoltaic glass supply chain efficiency [2] - Boying Special Welding's HRSG equipment is primarily matched with heavy gas turbines, with a production cycle of about 6 months, responding to increased demand in the U.S. market [3] Group 2 - Hongda Electronics' associate Jiangsu Zhanxin's application for IPO on the ChiNext has been accepted, with Hongda holding 13.79% of shares prior to the offering [5] - Yinxing Energy plans to acquire 50% stake in Tianjing Shenzhou for 20.15275 million yuan, which will enhance its renewable energy capacity [6] - Nandu Power's controlling shareholder has terminated plans for a change in control, leading to stock resumption on December 19, 2025 [7] Group 3 - Xibu Mining's subsidiary has obtained a mining license for iron resources, supporting sustainable development in the iron resource sector [9] - Shandong Expressway plans to provision for a long-term equity investment impairment of approximately 690 million yuan related to Dongxing Securities [10] - Tianfeng Securities has signed a supplementary agreement to extend the term of a 4 billion yuan subordinated debt by one year, with an adjusted interest rate of 4% [11] Group 4 - Shandong Zhanggu has received an administrative regulatory decision from the Shandong Securities Regulatory Commission for various compliance issues [12] - Nanjing Pharmaceutical plans to invest 120 million yuan to establish a medical device investment company, focusing on acquiring a stake in Ningbo Jiangfeng [13] - Hailianxun has received approval from the CSRC for a share swap merger with Hangzhou Steam Turbine, proceeding with related transactions [14] Group 5 - Luyuan Pharmaceutical reports normal operations with no significant changes in the internal and external business environment [15] - Nanhua Futures has set the H-share public offering price at 12 HKD per share, with expected listing on December 22, 2025 [17] - Visionox plans to invest 3.918 billion yuan in the second phase of the Hefei Guoxian AMOLED production line project, increasing its stake to 37.73% [18] Group 6 - Sichuan Road and Bridge has been acquired by Zhong Postal Insurance, reaching a 5% stake [19] - Boshuo Technology's directors plan to reduce their holdings by up to 18,300 shares [20] - O-film's controlling shareholder transferred 67.7048 million shares to settle debts, maintaining control with a 5.78% stake post-transfer [21] Group 7 - Junshi Biosciences' shareholder plans to reduce holdings by up to 2% through block trading [22] - Lihu Co. plans to reduce holdings by up to 2.98% through various trading methods [23] - Ruichen Environmental plans to reduce holdings by up to 3% through trading [25] Group 8 - Zhongfutong received a winning bid notification for a project worth approximately 411 million yuan [29] - Shikong Technology won a 141 million yuan project for smart cultural tourism integration [30] - Ningbo Construction's subsidiary won a 747 million yuan engineering project [31]

Group 1: Suspension of Trading - Zhongwei Company is planning to acquire the controlling stake of Hangzhou Zhonggui Electronic Technology through a share issuance and raise matching funds, resulting in a stock suspension [1] - Nandu Power's controlling shareholder has terminated the plan for a change in control, leading to the resumption of trading [1] Group 2: Shareholding and Buybacks - Sichuan Road and Bridge has been targeted by Zhongyou Insurance, increasing its shareholding to 5% [2] - Xizang Pharmaceutical plans to repurchase shares worth between 170 million to 200 million yuan, with a maximum repurchase price of 55 yuan per share [3] Group 3: Investments and Operations - Visionox intends to sign the "Investment Cooperation Agreement II" to advance the Hefei 8.6-generation AMOLED production line project, with a second-phase capital of 9.443 billion yuan [4] - Jiangnan New Materials plans to invest approximately 300 million yuan in the development and industrialization of high-end copper-based core materials in the Yingtan High-tech Industrial Development Zone [4] - Haitian Flavoring and Food will maintain a cash dividend ratio of no less than 80% annually for the next three years (2025-2027) [5] - Tianfeng Securities has signed a supplementary agreement to extend the maturity of its original 4 billion yuan subordinated debt by one year with its controlling shareholder Hongtai Group [5] - Qibin Group's subsidiary plans to establish a new energy company in Shenzhen with an investment of 600 million yuan [6] - Jiangsu Guoxin's subsidiary plans to increase capital by 1.8 billion yuan to advance its Phase III 2×100 MW expansion project [7] - Fosun Pharma's subsidiary has signed a "Cooperation and Option Agreement" with ClavisBio, potentially receiving up to 363 million USD in payments [7] - Baotai's application for marketing authorization of the injection of Vilasitamab (BAT5906) has been accepted [8] - Zhengye Technology has signed sales contracts for X-ray equipment totaling 120 million yuan [9] - Jinqilin's CRH380D train brake pads have passed small-scale trials [10]

★ 宏观动态 ★ 在今天（18日）下午召开的商务部例行新闻发布会上，新闻发言人何亚东针对稀土相关物项出口管制的最新进 展进行回应。商务部新闻发言人何亚东表示，对稀土相关物项实施出口管制以来，中方主管部门向中国出口商 进行了政策宣介，随着相关出口和合规经验的积累，部分中国出口商已初步达到申请通用许可的基本要求。据 我所知，目前已收到并批准了部分中国出口商提交的通用许可申请。 韩国计划孵化万家AI等硬科技初创企业 据新华社，韩国政府计划今后五年内在人工智能(AI)等硬科技领域孵化1万家初创企业，推动这些企业成长为 韩国经济发展的重要力量。韩联社报道说，韩国中小风险企业部12月18日会同有关部门发布"迈向全球四大创 投强国综合对策"并提出多个目标，包括孵化1万家AI等硬科技领域初创企业、打造50家独角兽和"十角兽"企 业、推动企业对接年规模约40万亿韩元（约合1904亿元人民币）的全球风险投资市场。 ★ 金融机构 ★ 中金公司：2025年半年度共计派发现金红利4.34亿元 国务院办公厅印发《关于全链条打击涉烟违法活动的意见》 国务院办公厅日前印发《关于全链条打击涉烟违法活动的意见》，提出一系列针对性政策举措，解决烟 ...

格隆汇12月18日丨四川路桥(600039.SH)公布，2025年12月17日，信息披露义务人中邮保险通过二级市 场买入股票的方式增持公司11.43万股股票，占公司总股本的0.0013%。 财经频道更多独家策划、专家专栏，免费查阅>> 责任编辑：山上 ...

Core Viewpoint - Sichuan Road and Bridge (600039.SH) announced that China Post Life Insurance Co., Ltd. increased its stake in the company by purchasing 114,300 shares through the secondary market, raising its total holdings to 435 million shares, which represents 5% of the company's total equity [1] Summary by Relevant Sections - **Shareholding Increase** - China Post Life Insurance acquired 114,300 shares, accounting for 0.0013% of the total equity [1] - **Total Holdings** - After the increase, China Post Life Insurance holds 435 million shares, which is 5% of the total share capital of Sichuan Road and Bridge [1] - **Impact on Control** - The equity change does not trigger a mandatory bid and will not result in any changes to the company's controlling shareholder or actual controller [1]

四川路桥建设集团股份有限公司 关于股东权益变动的提示性公告 证券代码：600039 证券简称：四川路桥 公告编号：2025-136 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次权益变动为股东增持股份，不触及要约收购。 本次权益变动后，中邮人寿保险股份有限公司（以下简称中邮保险或信 息披露义务人）持有四川路桥建设集团股份有限公司（以下简称公司）股份 434,779,540股，占公司总股本的5.00%。 本次权益变动不会导致公司控股股东、实际控制人发生变化。 公司于2025年12月18日收到信息披露义务人中邮保险出具的《简式权益变 动报告书》。本次权益变动是中邮保险基于自身发展投资需求和支持上市公司 持续健康发展的规划安排进行长期投资，截至本公告披露日，中邮保险持有公 司股份为434,779,540股，占公司总股本的5.00%。现将本次权益变动具体情况公 告如下： 一、本次权益变动基本情况 证券代码：600039 证券简称：四川路桥 公告编号：2025-136 | | 动；依法须经批准的项目，经相关部门批准 ...

智通财经APP讯，四川路桥(600039.SH)发布公告，2025年12月17日，中邮人寿保险股份有限公司通过 二级市场买入股票的方式增持公司11.43万股，占公司总股本的0.0013%。增持后，中邮保险持有公司 4.35亿股，占公司总股本的5%。此次权益变动不触及要约收购，且不会导致公司控股股东、实际控制 人发生变化。 ...

签署日期：2025年12月18日 上市公司名称： 四川路桥建设集团股份有限公司 上市地点： 上海证券交易所 股票简称： 四川路桥 股票代码： 600039.SH 四川路桥建设集团股份有限公司 简式权益变动报告书 信息披露义务人： 中邮人寿保险股份有限公司 信息披露义务人声明 住址： 北京市西城区金融大街甲3 号B 座6 层、7 层、8 层 通讯地址： 北京市西城区金融大街甲3 号B 座6 层、7 层、8 层 股份变动性质： 股份增加 截至本报告书签署日，除报告书披露的信息外，信息披露义务人没有通过 任何其他方式增加或减少其在四川路桥中拥有权益的股份。 四、本次权益变动是根据本报告所载明的资料进行的。信息披露义务人没 有委托或者授权其他任何人提供未在报告书中列载的信息和对本报告书做出任 何解释或者说明。 五、信息披露义务人承诺本报告书不存在虚假记载、误导性陈述或重大遗 漏，并对其真实性、准确性、完整性承担法律责任。 2 | ਮ | | --- | | | | 一、本信息披露义务人根据《中华人民共和国公司法》（以下简称"《公司 法》"）《中华人民共和国证券法》（以下简称"《证券法》"）《上市公司收购 管理办法》（ ...

四川路桥公告，中邮人寿保险股份有限公司于2025年12月17日通过二级市场买入股票方式增持公司 11.43万股，占公司总股本的0.0013%。权益变动后，中邮保险持有公司股份4.35亿股，占公司总股本的 5.00%。此次权益变动为股东增持股份，不触及要约收购，且不会导致公司控股股东、实际控制人发生 变化。 ...

四川路桥12月18日公告，中邮人寿保险股份有限公司于2025年12月17日通过二级市场买入股票方式增持 公司11.43万股，占公司总股本的0.0013%。权益变动后，中邮保险持有公司股份4.35亿股，占公司总股 本的5.00%。此次权益变动为股东增持股份，不触及要约收购，且不会导致公司控股股东、实际控制人 发生变化。 ...